CoPacker Index / Food Brand Daily
Food Brand Daily · Tuesday, October 6, 20268 food recalls and 8 new federal notices, most for other
Today's brief for food and beverage brands, built automatically from public FDA recall reports and the Federal Register. Nothing here is our opinion of any company.
What this means when you pick a co-packer
- Ask for the facility's latest third-party food safety audit and how they monitor the plant for pathogens. Questions to ask a co-packer
- Ask every co-packer how they handle allergen changeovers and who checks the label against the formula before a run. Questions to ask a co-packer
- Ask how the line checks for metal and other foreign material before product is packed. Questions to ask a co-packer
Food recalls in the latest FDA reports
- 8food recalls
- 3Class I, the most serious
- 0labeled organic
- 1allergen mentions
Why products were recalled
8 recalls in this report. Reasons are grouped by the words in each FDA report.
Allergens not on the label
- Evergreen Fresh Sprouts LLCMoyie Springs, IDClass I
Evergreen Fresh Sprouts LLC, Broccoli Sprouts, packaged in clear plastic zip lock bag, net wt. 4oz, UPC 8 38796 00105 1. Firm distributed cases (6/4oz. bags per case) to distributor.
Reason: Salmonella
FDA recall H-1390-2026, reported 2026-09-30, ongoing
- Gias Food Inc.New York, NYClass I
Lemon Alfredo Fettuccine packed in a yellow plastic sealed bag with pink and black lettering; label reads in part as "bettergoods Lemon Alfredo Fettuccine, MADE IN ITALY, NET WT 22 OZ, BEST if Used By: SEP 20 2027 L6080C, UPC...
Reason: Contamination with Listeria monocytogenes
FDA recall H-1396-2026, reported 2026-09-30, ongoing
- Wfm Purchasing, LpAustin, TXClass I
Fromagerie Coop de Mean Cabricharme and Belgium Cabricharme Shelf life: 30 days, all dates through and including 10/7/2026 Packaging: Plastic wrapped by slice Net Wt.: Various, cut from whole wheel and priced by weight with Whole Foods...
Reason: Undeclared Egg Allergen
FDA recall H-1395-2026, reported 2026-09-30, ongoing
- Elegant Foods, LLCMadison, WIClass II
Pecorino Toscano D.O.P. STAGIONATO cheese wheels. Product of Italy. Each cheese wheel is approximately 3-4 lbs. Wheels contain a wax rind. Keep Refrigerated. Produced by Soc. Cooperativa Val D'Orcia Aocieta Agricola
Reason: Potential Listeria contamination from dripping condensation in cooler.
FDA recall H-1389-2026, reported 2026-09-30, ongoing
- United Sugar Producers And RefinersMinneapolis, MNClass II
Light Brown Sugar, Packaged in he follow configurations: 1. United, Net Wt. 50 lbs., (22.68kg). Item Number 810051. Distributed By: United Sugar Producers & Refiners, Minneapolis, MN 55439. 2. Good & Gather, Net Wt 2 lb. (32 oz) 907g....
Reason: Potential Wheat Kernel contamination.
FDA recall H-1391-2026, reported 2026-09-30, ongoing
- United Sugar Producers And RefinersMinneapolis, MNClass II
Powdered Sugar, Packaged in the following configurations: 1. United 6X, Net Wt. 50 lbs. (22.68kg), Item Number 810087. UPC 7 85921-07090 4. Distributed by: United Sugar Producers & Refiners, Minneapolis, MN 55439. 2. Crystal Sugar, Net...
Reason: Potential Wheat Kernel contamination.
FDA recall H-1392-2026, reported 2026-09-30, ongoing
- Wwf Operating CompanyLouisville, COClass II
So Delicious Dairy Free Salted Caramel Cluster Cashewmilk, Non-Dairy Frozen Dessert. 16 oz paper tub with an attached paper lid. Sold as a single unit multi serving tub. UPC 744473 476138. Distributed by For So Delicious Dairy Free...
Reason: Product may contain foreign material: small stones and other hard objects.
FDA recall H-1394-2026, reported 2026-09-30, ongoing
- Kwok Shing, Inc.San Francisco, CAClass III
American Ginsengs. PRODUCT OF WISCONSIN. NET WT: 4 oz. NET WT. 8 oz.
Reason: Potential contamination with pesticides.
FDA recall H-1393-2026, reported 2026-09-30, ongoing
New in the Federal Register
Rules, proposed rules, and notices from the FDA and USDA that touch food, labels, and organic.
- Rule · Health and Human Services Department
Medical Devices; Cardiovascular Devices; Classification of the Hyperoxia Monitoring Device Adjunct to Pulse Oximetry
The Food and Drug Administration (FDA) is classifying the hyperoxia monitoring device adjunct to pulse oximetry into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the hyperoxia monitoring device adjunct to pulse oximetry. We are taking this action because we have determined that classifying...
- Rule · Health and Human Services Department
Medical Devices; Exemptions From Premarket Notification: Class II Devices; Certain Clinical Toxicology Test Systems
The Food and Drug Administration (FDA) is publishing an order setting forth its final determination to exempt certain class II clinical toxicology test systems from premarket notification (510(k)) requirements, subject to certain limitations. This exemption from 510(k) requirements, subject to certain limitations, is immediately in effect for such devices. This exemption will decrease regulatory burdens on the...
- Rule · Health and Human Services Department
Medical Devices; General and Plastic Surgery Devices; Classification of the Focused Ultrasound System for Non-Thermal, Mechanical Tissue Ablation
The Food and Drug Administration (FDA) is classifying the focused ultrasound system for non-thermal, mechanical tissue ablation into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the focused ultrasound system for non-thermal, mechanical tissue ablation. We are taking this action because we...
- Rule · Health and Human Services Department
Medical Devices; Immunology and Microbiology Devices; Classification of the High Throughput DNA Sequencing for Hereditary Cancer Predisposition Assessment Test System
The Food and Drug Administration (FDA) is classifying the high throughput DNA sequencing for hereditary cancer predisposition assessment test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the high throughput DNA sequencing for hereditary cancer predisposition assessment test...
- Notice · Health and Human Services Department
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information
The Food and Drug Administration (FDA or the Agency) is describing the approaches it is considering for the design of early- phase clinical trials of ibogaine drug products and is opening a public docket to receive comments. The Department of Health and Human Services (HHS) is funding clinical development of ibogaine, and the first federally supported trials are expected to study ibogaine in adults with opioid use...
- Notice · Health and Human Services Department
Determination PRALIDOXIME CHLORIDE (Autoinjector) (Pralidoxime Chloride) Solution, 600 Milligrams/2 Milliliters (300 Milligrams/Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA, Agency, or we) has determined that PRALIDOXIME CHLORIDE (AUTOINJECTOR) (pralidoxime chloride) solution, 600 milligrams (mg)/2 milliliters (mL) (300 mg/mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for pralidoxime chloride solution, 600 mg/2 mL (300 mg/mL), if all...
- Notice · Health and Human Services Department
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FAYUVI (rebisufligene etisparvovec-hopf)
The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority...
- Notice · Health and Human Services Department
Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications; Correction
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on May 7, 2026. The document announced the withdrawal of approval of 15 abbreviated new drug applications (ANDAs) from multiple applicants, withdrawn as of June 8, 2026. The document indicated that FDA was withdrawing approval of ANDA 210285 for dimethyl fumarate delayed-release capsule, 120 milligrams (mg) and 240...
Summaries are the agencies' own words. Read the full document before you act on it.
Looking for a certified co-packer?
Describe your product and get a free launch plan with every USDA organic certified co-packer that fits.
Build my launch planSources: openFDA food enforcement reports and the Federal Register API. Recall details are copied from FDA reports and may be updated by the FDA. CoPacker Index is not affiliated with the FDA or USDA.